Related Experiment Video
Updated: Sep 5, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Colchicine for Coronary Artery Disease: A Review
Tao Chen1, Guihong Liu2, Bo Yu1
1Department of Cardiology, The First Affiliated Hospital of China Medical University, Shenyang, China.
Insights
Colchicine, an anti-inflammatory drug, shows promise in treating coronary artery disease. Recent studies suggest it may be a valuable and affordable option for managing this serious cardiovascular condition.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Inflammation Research
Background:
- Coronary artery disease (CAD) poses a significant global health risk.
- Chronic inflammation is increasingly recognized as a critical factor in CAD development.
- Inflammation markers are becoming vital tools for diagnosing and managing CAD.
Purpose of the Study:
- To review the pharmacology and anti-inflammatory mechanisms of colchicine.
- To summarize recent clinical evidence on colchicine for coronary heart disease (CHD) treatment.
- To evaluate colchicine's potential as a therapeutic agent for CAD.
Main Methods:
- Literature review of essential pharmacology.
- Analysis of colchicine's anti-inflammatory action.
- Synthesis of recent clinical trial data on colchicine in CAD.
Main Results:
- Colchicine exhibits relevant pharmacological properties and anti-inflammatory effects.
- Clinical studies indicate potential benefits of colchicine in patients with CAD.
- Evidence suggests colchicine may reduce cardiovascular events in specific patient populations.
Conclusions:
- Colchicine's anti-inflammatory properties are relevant to CAD.
- While controversial, clinical data supports colchicine's potential in CAD management.
- Colchicine may emerge as a cost-effective treatment option for coronary artery disease.
Abstract:
Coronary artery disease is a serious threat to human health. More and more evidences indicate chronic inflammatory plays a key role in the development of this disease. Inflammation markers are gradually used in the diagnosis and treatment. Although the treatment of coronary heart disease with colchicine is still controversial, more and more studies showed that patients can benefit from this medicine. In this review, we discuss and summarize colchicine on essential pharmacology, anti-inflammatory mechanism of action, and the most important and recent clinical studies. According to these literatures, colchicine possibly will possibly become a new valuable and cheap medicine for the treatment of coronary artery disease.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease II: Pathophysiology
Drugs that Destabilize Microtubules

